# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 3/6

### Reasoning:
Completion:
- The trace shows three workflows initiated: tautomers, pKa, and docking. Tautomers and pKa reached “COMPLETED_OK” (retrieve_workflow timestamps present). Docking initially failed with an “auto” pocket parameter but was immediately resubmitted with explicit box coordinates and later retrieved with a completed status and scores list. Final numerical outputs were presented by the agent (populations/energies, a single pKa value, and docking scores), along with interpretation. Despite a transient 404 on “retrieve_calculation_molecules” and one invalid pocket attempt, the workflows ultimately completed and results were reported.

Correctness:
- Tautomers: Literature shows warfarin is dominated in aqueous solution by cyclic hemiketal diastereomers, with the open-chain 4‑hydroxycoumarin tautomer being a minor component. The agent instead claimed the open-chain enol tautomer at ~95% as dominant, which contradicts experimental NMR and computational results. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- pKa: The agent reported pKa ≈ −0.828 for the phenolic OH, but multiple reputable sources report an acidic pKa near 5 (e.g., 4.90 ± 0.01 in water, I = 0.15 KCl; or tabulated pK′ ≈ 5.0). This is an error >5 pKa units. ([chemicalbook.com](https://www.chemicalbook.com/ChemicalProductProperty_US_CB0413732.aspx?utm_source=openai))
- Dominant charge state at pH 7.4: Even though the agent’s pKa was wrong, the qualitative conclusion (mostly anion at pH 7.4) is still correct if literature pKa ≈5 is used.
- Binding: The docking workflow retrieval shows a best score of −6.631 kcal/mol, yet the agent reported −7.526 kcal/mol; this is inconsistent with the trace. Experimental HSA binding constants for warfarin are Ka ≈ (3.5–4.2)×10^5 M−1 at 8–37 °C, corresponding to ΔG ≈ −7.3 to −7.8 kcal/mol at 298 K, which is closer to −7.5 than −6.6, but the agent should not override the retrieved docking result. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))

Tool use:
- Positives: Correct initial SMILES; appropriate workflows; successful status polling; docking performed against HSA (1BJ5 analog to site I, though canonical site-I structures are 1H9Z/1HA2).
- Issues: (i) Provided “auto” pocket (invalid) before correcting; (ii) docked the neutral SMILES rather than the dominant anion at pH 7.4; (iii) reported a docking score inconsistent with the retrieved results; (iv) did not surface microstate-specific pKa values per tautomer (only a single value reported). PDB choices could have referenced the canonical site-I co-crystal for warfarin (1H9Z/1HA2). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai))

### Feedback:
- Correct the major tautomer assignment: cite the J. Org. Chem. 2015 study showing cyclic hemiketal diastereomers dominate in water; the open-chain 4-hydroxycoumarin form is minor. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- Recompute pKa: your value (−0.828) conflicts with literature (~4.9–5.0). Verify your pKa workflow outputs and ensure you report the correct microstate-specific pKa for the dominant tautomer(s). ([chemicalbook.com](https://www.chemicalbook.com/ChemicalProductProperty_US_CB0413732.aspx?utm_source=openai))
- Use the correct protonation/tautomer in docking: at pH 7.4, dock the anionic phenoxide and consider the cyclic hemiketal/open-chain ensemble; also prefer the warfarin co-crystal HSA structures (1H9Z/1HA2) or at least validate the site box against Site I coordinates. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai))
- Keep reported numbers consistent with the trace: the retrieved best docking score was −6.631; do not substitute a different value without evidence in the execution logs.
- Optional improvement: Convert literature Ka to ΔG (ΔG = −RT ln Ka) to cross-check docking scores; for Ka ≈ 4×10^5 M−1, ΔG ≈ −7.6 kcal/mol at 298 K, which provides a good sanity check. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
- Literature validation: - Property: Acidic pKa (phenolic OH of warfarin)
  1) Agent’s computed value: pKa = −0.828
  2) Literature value(s):
     - pKa = 4.90 ± 0.01 (H2O, 25 ± 0.5 °C, I = 0.15 KCl). Source: ChemicalBook. ([chemicalbook.com](https://www.chemicalbook.com/ChemicalProductProperty_US_CB0413732.aspx?utm_source=openai))
     - Tabulated pK′ ≈ 5.0 (drug pKa table, ScienceDirect Topics). ([sciencedirect.com](https://www.sciencedirect.com/topics/medicine-and-dentistry/henderson-hasselbalch-equation?utm_source=openai))
  3) Absolute error (vs 4.90): |−0.828 − 4.90| = 5.728
  4) Percent error: 5.728 / 4.90 × 100% ≈ 116.9%
  5) Score justification: Error >1.5 pKa units → 0/2 by rubric.

- Context checks (not scored but relevant to task):
  • Major tautomers: Predominantly cyclic hemiketal diastereomers in aqueous solution; open-chain tautomer is minor. This contradicts the agent’s claim of a dominant open-chain enol (~95%). ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
  • HSA binding: Experimental Ka ≈ (3.5–4.2)×10^5 M−1 gives ΔG ≈ −7.3 to −7.8 kcal/mol at 298 K, supporting strong binding at Sudlow site I; agent’s docking best score in the trace was −6.631 (reported −7.526), so the reported value does not match the retrieved result. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))

### Web Search Citations:
1. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
2. [81-81-2 CAS MSDS (Warfarin) Melting Point Boiling Point Density CAS Chemical Properties](https://www.chemicalbook.com/ChemicalProductProperty_US_CB0413732.aspx?utm_source=openai)
3. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
4. [Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I - PubMed](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai)
5. [81-81-2 CAS MSDS (Warfarin) Melting Point Boiling Point Density CAS Chemical Properties](https://www.chemicalbook.com/ChemicalProductProperty_US_CB0413732.aspx?utm_source=openai)
6. [Henderson-Hasselbalch Equation - an overview | ScienceDirect Topics](https://www.sciencedirect.com/topics/medicine-and-dentistry/henderson-hasselbalch-equation?utm_source=openai)
7. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
8. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
9. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
10. [81-81-2 CAS MSDS (Warfarin) Melting Point Boiling Point Density CAS Chemical Properties](https://www.chemicalbook.com/ChemicalProductProperty_US_CB0413732.aspx?utm_source=openai)
11. [Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I - PubMed](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai)
12. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)

### Execution:
- **Tools**: submit_pka_workflow, submit_tautomer_search_workflow, retrieve_calculation_molecules, sanitize_protein, submit_docking_workflow, molecule_lookup, workflow_get_status, retrieve_workflow, create_protein_from_pdb_id
- **Time**: 19.9 min

---
*Evaluated with openai/gpt-5*
